Skip to content

Pulmonx Corporation LUNG Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
LivaNova logo
LivaNovaLIVN
ResMed logo
ResMedRMD
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-43.7%
Enterprise value$50.17M-39.2%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's common stock, par value (in dollars per share)?
Pulmonx Corporation (LUNG) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
How has Pulmonx Corporation's common stock, par value (in dollars per share) changed year-over-year?
Pulmonx Corporation's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Pulmonx Corporation's common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Pulmonx Corporation's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.